Detalhe da pesquisa
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
2.
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 25(6): 744-759, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821083
3.
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Br J Haematol
; 197(5): 590-601, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365860
4.
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.
J Med Internet Res
; 22(5): e17018, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406858
5.
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Haematologica
; 100(4): 525-33, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512643
6.
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry.
Ann Hematol
; 93(10): 1705-15, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24807105
7.
Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Eur J Haematol
; 93(3): 229-38, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24702126
8.
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.
Eur J Haematol
; 92(5): 398-406, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24400940
9.
A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.
Haematologica
; 98(3): 479-86, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22929981
10.
The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress.
J Cancer Surviv
; 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755680
11.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
EClinicalMedicine
; 63: 102167, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680948
12.
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Blood Cancer J
; 12(3): 38, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264598
13.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240075
14.
A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands.
Leuk Lymphoma
; 62(3): 549-559, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213245
15.
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Blood Cancer J
; 14(1): 3, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177115
16.
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study.
Blood Adv
; 7(17): 4869-4873, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389820
17.
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Blood Cancer J
; 12(9): 125, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055987
18.
Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015.
Blood Adv
; 1(21): 1839-1841, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297513